Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8941057rdf:typepubmed:Citationlld:pubmed
pubmed-article:8941057lifeskim:mentionsumls-concept:C0285526lld:lifeskim
pubmed-article:8941057lifeskim:mentionsumls-concept:C0262950lld:lifeskim
pubmed-article:8941057lifeskim:mentionsumls-concept:C0221102lld:lifeskim
pubmed-article:8941057lifeskim:mentionsumls-concept:C0014912lld:lifeskim
pubmed-article:8941057lifeskim:mentionsumls-concept:C0029453lld:lifeskim
pubmed-article:8941057lifeskim:mentionsumls-concept:C1524119lld:lifeskim
pubmed-article:8941057lifeskim:mentionsumls-concept:C0449864lld:lifeskim
pubmed-article:8941057lifeskim:mentionsumls-concept:C0243127lld:lifeskim
pubmed-article:8941057lifeskim:mentionsumls-concept:C0392747lld:lifeskim
pubmed-article:8941057lifeskim:mentionsumls-concept:C0677922lld:lifeskim
pubmed-article:8941057lifeskim:mentionsumls-concept:C0443172lld:lifeskim
pubmed-article:8941057lifeskim:mentionsumls-concept:C0439828lld:lifeskim
pubmed-article:8941057lifeskim:mentionsumls-concept:C0443331lld:lifeskim
pubmed-article:8941057pubmed:issue6lld:pubmed
pubmed-article:8941057pubmed:dateCreated1997-1-2lld:pubmed
pubmed-article:8941057pubmed:abstractTextTo evaluate the effectiveness of N-telopeptides and E2 in monitoring bone turnover during GnRH agonist- (GnRH-a) or danazol-induced hypoestrogenism.lld:pubmed
pubmed-article:8941057pubmed:languageenglld:pubmed
pubmed-article:8941057pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8941057pubmed:citationSubsetIMlld:pubmed
pubmed-article:8941057pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8941057pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8941057pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8941057pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8941057pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8941057pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8941057pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8941057pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8941057pubmed:statusMEDLINElld:pubmed
pubmed-article:8941057pubmed:monthDeclld:pubmed
pubmed-article:8941057pubmed:issn0015-0282lld:pubmed
pubmed-article:8941057pubmed:authorpubmed-author:RanaNNlld:pubmed
pubmed-article:8941057pubmed:authorpubmed-author:DmowskiW PWPlld:pubmed
pubmed-article:8941057pubmed:authorpubmed-author:ColeF RFRlld:pubmed
pubmed-article:8941057pubmed:authorpubmed-author:CainD FDFlld:pubmed
pubmed-article:8941057pubmed:authorpubmed-author:PeppingPPlld:pubmed
pubmed-article:8941057pubmed:issnTypePrintlld:pubmed
pubmed-article:8941057pubmed:volume66lld:pubmed
pubmed-article:8941057pubmed:ownerNLMlld:pubmed
pubmed-article:8941057pubmed:authorsCompleteYlld:pubmed
pubmed-article:8941057pubmed:pagination929-36lld:pubmed
pubmed-article:8941057pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:8941057pubmed:meshHeadingpubmed-meshheading:8941057-...lld:pubmed
pubmed-article:8941057pubmed:meshHeadingpubmed-meshheading:8941057-...lld:pubmed
pubmed-article:8941057pubmed:meshHeadingpubmed-meshheading:8941057-...lld:pubmed
pubmed-article:8941057pubmed:meshHeadingpubmed-meshheading:8941057-...lld:pubmed
pubmed-article:8941057pubmed:meshHeadingpubmed-meshheading:8941057-...lld:pubmed
pubmed-article:8941057pubmed:meshHeadingpubmed-meshheading:8941057-...lld:pubmed
pubmed-article:8941057pubmed:meshHeadingpubmed-meshheading:8941057-...lld:pubmed
pubmed-article:8941057pubmed:meshHeadingpubmed-meshheading:8941057-...lld:pubmed
pubmed-article:8941057pubmed:meshHeadingpubmed-meshheading:8941057-...lld:pubmed
pubmed-article:8941057pubmed:meshHeadingpubmed-meshheading:8941057-...lld:pubmed
pubmed-article:8941057pubmed:meshHeadingpubmed-meshheading:8941057-...lld:pubmed
pubmed-article:8941057pubmed:meshHeadingpubmed-meshheading:8941057-...lld:pubmed
pubmed-article:8941057pubmed:meshHeadingpubmed-meshheading:8941057-...lld:pubmed
pubmed-article:8941057pubmed:meshHeadingpubmed-meshheading:8941057-...lld:pubmed
pubmed-article:8941057pubmed:meshHeadingpubmed-meshheading:8941057-...lld:pubmed
pubmed-article:8941057pubmed:year1996lld:pubmed
pubmed-article:8941057pubmed:articleTitleExcretion of urinary N-telopeptides reflects changes in bone turnover during ovarian suppression and indicates individually variable estradiol threshold for bone loss.lld:pubmed
pubmed-article:8941057pubmed:affiliationInstitute for the Study and Treatment of Endometriosis, Columbia Grant Hospital, Chicago, Illinois, USA.lld:pubmed
pubmed-article:8941057pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8941057pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:8941057pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed